MIF is a HIF1α-dependent hypoxia-inducible gene. (A) Northern analyses of Ad-empty-infected or Ad-Cre-infected HIF1αfl/fl MEFs in normoxia (Nx) or 2% O2 (Hyp). GLUT1 and MIF transcript expression are shown, as well as the ethidium bromide-stained gel as a loading control. (B) Western analyses of cells treated as in A. The immunoblots were probed with antibodies for MIF or α-tubulin as indicated. Molecular weight markers in kilodaltons. (C) Promoter analysis of the −70 to +63 region of the murine MIF promoter. Promoter fragments were cloned into pGL3promoter; a 5XHRE construct, including five copies of the human VEGF HRE, serves as a positive control. Constructs (identified by the letters A–G in the middle of the figure) are schematically represented in the bar diagram on the left, while their relative promoter activities in normoxia (black bars) and hypoxia (gray bars) are displayed on the right of the figure. Arrows at the bottom of the bar diagram indicate the regions that are essential for promoter activity. (D) Promoter regions determined to be required for promoter activity in C. Putative promoter-binding sites were identified by computer database analysis (http://www.genomatrix.de). Four nucleotide mutations in the core of each site are indicated. (E) Luciferase assays of construct C with specific mutations identified in D. Mutations of the four core nucleotides of each site were made alone or in combination, as indicated at the bottom of the bar graph. (F) ChIP analysis of the murine MIF promoter. Genomic DNA from the mouse keratinocyte cell line (Balb/MK) was fixed and immunoprecipitated with either IgG or an α-HIF1α antibody. Subsequently, PCR was performed with primers specific to the GLUT1 HRE, putative MIF HRE, or upstream MIF sequences (MIF control). Error bars indicate standard deviation.